Market revenue in 2023 | USD 5,712.9 million |
Market revenue in 2030 | USD 9,741.8 million |
Growth rate | 7.9% (CAGR from 2023 to 2030) |
Largest segment | Covid-19 testing |
Fastest growing segment | Glucose testing |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Glucose testing, A1C testing, Direct LDL testing, Lipid panel testing, Prostate-specific antigen testing, COVID-19 testing, BUN testing, Vitamin D testing, Thyroid-stimulating hormone testing, Serum Nicotine / Cotinine testing, High sensitivity CRP testing, Testosterone testing, ALT testing, Cortisol testing, Creatinine testing, AST testing, Other blood tests |
Key market players worldwide | Abbott Laboratories, Roche Holding AG ADR, Bio-Rad Laboratories Inc, BioMerieux SA, Quest Diagnostics Inc, Biomerica Inc, Becton Dickinson & Co, Siemens Healthineers AG ADR, Danaher Corp, Trinity Biotech PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood testing market will help companies and investors design strategic landscapes.
Covid-19 testing was the largest segment with a revenue share of 24.04% in 2023. Horizon Databook has segmented the Middle East & Africa blood testing market based on glucose testing, a1c testing, direct ldl testing, lipid panel testing, prostate-specific antigen testing, covid-19 testing, bun testing, vitamin d testing, thyroid-stimulating hormone testing, serum nicotine / cotinine testing, high sensitivity crp testing, testosterone testing, alt testing, cortisol testing, creatinine testing, ast testing, other blood tests covering the revenue growth of each sub-segment from 2018 to 2030.
Rising prevalence of non-communicable diseases in the region, increasing initiatives being undertaken by the government to reduce incidence of these diseases, and rising awareness are factors anticipated to fuel the market growth.
Growing awareness about available healthcare, various initiatives being undertaken by various organizations, increasing penetration of health insurance, and privatization of healthcare are some of the factors anticipated to fuel the market growth in this region.
Lack of a well-defined regulatory framework and scarcity of skilled healthcare professionals for diagnosis & treatment are anticipated to hinder the MEA market growth. However, increase in government initiatives to improve healthcare infrastructure in South Africa, Saudi Arabia, and the UAE is creating new opportunities for blood testing market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa blood testing market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa blood testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account